Tightening PFAS regulation and supplier exits threatened a MedTech maker's supply chain. Trexin ran a structured outreach across 3,000+ suppliers (3,085 contacted, 1,971 reaching complete status) to inventory 'forever chemicals' for compliance and continuity.
A multibillion-dollar medical-technology manufacturer faced supply-chain disruption as PFAS (“forever chemical”) regulations tightened and major suppliers halted PFAS production, risking recalls, delays, and cost on life-saving devices. The Client needed to inventory PFAS across a network of 3,000+ suppliers and get ahead of upcoming bans.
We organized supplier outreach into distinct workstreams for cleaner workflow and resource use, categorizing suppliers by responsiveness and priority (by operating unit). High-priority suppliers got direct engagement to maximize response and data accuracy; lower-priority ones moved through automated outreach. Open dialogue about PFAS use encouraged participation, and process-flow documentation kept everyone aligned to the Client’s goals.
By project end, 3,085 suppliers were contacted, 1,530 surveys completed, and 1,971 suppliers reached complete status, a precise read on PFAS presence across products and processes. The work reinforced the Client’s regulatory compliance and environmental commitments and supported supply-chain continuity.
Targeted engagement and clear communication to get ahead of a regulatory disruption, not just react to it.
case study
case study
event
Tell us what you're trying to do. A senior practitioner will read it.
Talk to us